Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Pleuritic chest pain.

Marks M, Murch NR, Beckles MA, Drebes AB, Beynon HL.

Lancet. 2013 Nov 30;382(9907):e32. doi: 10.1016/S0140-6736(13)62547-7. No abstract available.

PMID:
24290590
2.

Images in clinical medicine: Wound botulism.

Sam AH, Beynon HL.

N Engl J Med. 2010 Dec 16;363(25):2444. doi: 10.1056/NEJMicm1003352. No abstract available.

3.

Supplements and injections for joint disease.

Derrett-Smith E, Beynon HL.

Br J Hosp Med (Lond). 2006 Jun;67(6):290-3. Review. Erratum in: Br J Hosp Med (Lond). 2006 Aug;67(8):439.

PMID:
16821730
4.

Jo-1 syndrome with associated poorly differentiated adenocarcinoma.

Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HL.

Rheumatology (Oxford). 2004 Mar;43(3):389-90. Review. No abstract available.

PMID:
14963208
5.

Endocrine and reproductive manifestations of sarcoidosis.

Porter N, Beynon HL, Randeva HS.

QJM. 2003 Aug;96(8):553-61. Review. No abstract available.

PMID:
12897340
6.

The neurological complications of systemic sarcoidosis.

Kidd D, Beynon HL.

Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):85-94. Review.

PMID:
12870717
7.

Psoriasis: response to high-dose intravenous immunoglobulin in three patients.

Gurmin V, Mediwake R, Fernando M, Whittaker S, Rustin MH, Beynon HL.

Br J Dermatol. 2002 Sep;147(3):554-7.

PMID:
12207600
8.

Nuclear factor-kappaB activation in alveolar macrophages requires IkappaB kinase-beta, but not nuclear factor-kappaB inducing kinase.

Conron M, Andreakos E, Pantelidis P, Smith C, Beynon HL, Dubois RM, Foxwell BM.

Am J Respir Crit Care Med. 2002 Apr 1;165(7):996-1004.

PMID:
11934728
9.

Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways.

Conron M, Bondeson J, Pantelidis P, Beynon HL, Feldmann M, duBois RM, Foxwell BM.

Am J Respir Cell Mol Biol. 2001 Aug;25(2):141-9.

PMID:
11509322
10.

Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis.

Conron M, Beynon HL.

Sarcoidosis Vasc Diffuse Lung Dis. 2000 Oct;17(3):277-80.

PMID:
11033844
11.

Churg-Strauss syndrome.

Conron M, Beynon HL.

Thorax. 2000 Oct;55(10):870-7. Review. No abstract available.

12.

Calcium metabolism in sarcoidosis and its clinical implications.

Conron M, Young C, Beynon HL.

Rheumatology (Oxford). 2000 Jul;39(7):707-13.

PMID:
10908687
13.

Lupus erythematosus vegetans.

Khorshid SM, Beynon HL, Rustin MH.

Br J Dermatol. 1999 Nov;141(5):893-6.

PMID:
10583174
14.

Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease.

Botto M, Theodoridis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA, Walport MJ, Davies KA.

Clin Exp Immunol. 1996 May;104(2):264-8.

15.

Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.

Beynon HL, Davies KA, Haskard DO, Walport MJ.

J Immunol. 1994 Oct 1;153(7):3160-7.

PMID:
8089493
16.

Jaw claudication and amaurosis fugax secondary to atheromatous disease of the carotid arteries.

Webster G, Beynon HL, Walport MJ.

Br J Rheumatol. 1994 Jul;33(7):691-2. No abstract available.

PMID:
8019808
17.

Vascular endothelial injury by intravascular contrast agents.

Beynon HL, Walport MJ, Dawson P.

Invest Radiol. 1994 Jun;29 Suppl 2:S195-7. No abstract available.

PMID:
7928227
18.

Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus.

Davies KA, Beynon HL, Walport MJ.

BMJ. 1994 Jan 8;308(6921):133. No abstract available.

19.

Splenic uptake of immune complexes in man is complement-dependent.

Davies KA, Erlendsson K, Beynon HL, Peters AM, Steinsson K, Valdimarsson H, Walport MJ.

J Immunol. 1993 Oct 1;151(7):3866-73.

PMID:
8376807
20.

In vitro production of tumor necrosis factor by monocytes cultured from dialysis patients.

Ryan JJ, Beynon HL, Rees AJ, Cassidy MJ.

Kidney Int Suppl. 1993 Jun;41:S226-9.

PMID:
8320927
21.

Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers.

Beynon HL, Haskard DO, Davies KA, Haroutunian R, Walport MJ.

Clin Exp Immunol. 1993 Feb;91(2):314-9.

22.

Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Davies KA, Peters AM, Beynon HL, Walport MJ.

J Clin Invest. 1992 Nov;90(5):2075-83.

23.

Antiphospholipid antibodies and cardiovascular disease.

Beynon HL, Walport MJ.

Br Heart J. 1992 Apr;67(4):281-4. Review. No abstract available.

24.

Ganciclovir treatment for cytomegalovirus infection in immunocompromised patients with renal disease.

Ross CN, Beynon HL, Savill JS, Watkins RP, Cohen J, Pusey CD, Rees AJ.

Q J Med. 1991 Nov;81(295):929-36.

PMID:
1667044
25.

Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ.

Q J Med. 1990 Oct;77(282):1019-38. Review.

PMID:
2267280
26.

Meningococcal endophthalmitis and pericarditis.

Beynon HL, Hague S.

J R Soc Med. 1990 May;83(5):331. No abstract available.

27.

Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone.

Beynon HL, Garbett ND, Barnes PJ.

Lancet. 1988 Aug 13;2(8607):370-2.

PMID:
2899776

Supplemental Content

Loading ...
Support Center